by Lancet Credit: CC0 Public Domain Monthly prophylactic injections of fitusiran are effective in reducing bleeds in patients with hemophilia A or B, according to randomized controlled trials publishing simultaneously in The Lancet and The Lancet Haematology journals. Hemophilia is a lifelong, inherited bleeding disorder, which mostly affects men and results in patients with hemophilia A or B missing partially...
